Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Association for Water, Applied Education & Renewable Energy (AWARE)
Street 1: Office of AWARE
Street 2: Near National Bank
City: Chachro, Tharparkar
Province: Sindh
Post Code: 69170
Country: Pakistan
Phone: 0092232273054
Email: info@aware.org.pk
Web Site: http://www.aware.org.pk

Focal Point Contact Information

Salutation: Mr
First Name: Ali Akbar
Last Name: Rahimoo
Title: Executive Director
Email: aliakbar@aware.org.pk
Phone: +923337092067

Alternate Focal Point Contact Information

Salutation: Mr
First Name: Manzoor
Last Name: Hassan
Title: Program Coordinator
Email: awareumarkot@yahoo.com
Phone: +9223850039

General Information

Board Constituency: Developing Country NGO
Organization Type - Primary: Non-Governmental Organization
Organization Type - Secondary: Other Non-Governmental Organization (NGO)
Is your organization legally registered in your country: Yes
Organization Reach: National
Organization Description:
1. AWARE is an indegenous registered nont for profit organization working in Thar desert. for further deatils plz visit www.aware.org.pk
2. AWARE is running a clinic in Thar, there is observed that people attended cilinic has high rate of TB n patients r not recognizing the seriousness of disease. so AWARE has decided to work on health education/awareness raising as well as taking measures to cushion the hardships of suffering souls.
3. AWARE has developed links with health organizations/Govt health deptt to take initiatives with collaboration, but still not got any concrete results.
 
Total number of staff in your organization: 11 - 25
Number of full-time staff who are directly involved with TB: 6 - 10
Number of part-time staff who are directly involved with TB: 11 - 25
Number of volunteers who are directly involved with TB: Unknown
 
What is your organization's annual budget (USD) dedicated to TB? $25,000-$100,000
How did you hear about the Stop TB Partnership: Other partners
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Network with other partners
 
Are you a member of a Stop TB national partnership: Pakistan
Are you in contact with your national TB programme: Yes
Please tell us how your organization is contributing to your country's national TB control plan:
 
 

Geographical Reach

Which country is your headquarters located in: Pakistan
Which WHO region is the main focus of your work: South East Asian
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Pakistan

Specializations

Advocacy
Delivery of health services and care
Funding, including innovative and optimized approach to funding TB Care
Research and Development
Technical Assistance

Specializations in Countries

Advocacy Pakistan

Contribution

Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
Tuberculosis (TB) is a contagious lung disease that spreads through the air. When people with the disease cough, sneeze, talk or spit, they propel TB germs, known as bacilli, into the air. Only a small number of the bacilli need to be inhaled to cause an infection. However, not all people infected with TB bacilli will become sick. The immune system either kills the germs, or "walls off" the TB bacilli where they can lie dormant for years. Failure of the immune system to control infection with TB bacilli leads to active disease, when TB bacilli multiply and cause damage in the body. Left untreated, each person with infectious TB will spread the germs to about 10 to 15 people every year.

Someone in the world is newly infected with TB bacilli every second.

Overall, one third of the world's population is currently infected with TB.

5% to 10% of people who are infected with TB become actively sick.

When a person with infectious TB is identified (using a microscope to look for bacilli in a sample of a person's sputum), a full course of the correct dosage of anti-TB medicines should be started, with support of health and community workers or trained volunteers. The most common anti-TB medicines are isoniazid, rifampicin, pyrazinamide and ethambutol.

Supervised treatment helps to ensure that an infected person completes the course of medicine to cure TB and prevent its further spread. Treatment must be continued regularly and uninterrupted for six to eight months. The internationally recommended approach to TB control is DOTS, which is a cost-effective public health strategy to identify and cure TB patients. The approach will prevent millions of TB cases and deaths over the coming decade.

10 facts about tuberculosis

More than two billion people – one third of the world’s total population – are infected with TB bacilli, the microbes that cause TB.

One in every 10 of those people will become sick with active TB in his or her lifetime. People living with HIV are at a much greater risk.

WHO aims to reach all patients through health systems and primary health care and is working with other agencies to achieve the target under the Millennium Development Goals (MDG).

Fact 1
Tuberculosis (TB) is contagious and spreads through the air. If not treated, each person with active TB can infect on average 10 to 15 people a year.

Fact 2
More than two billion people, equal to one third of the world’s total population, are infected with TB bacilli, the microbes that cause TB. One in every 10 of those people will become sick with active TB in his or her lifetime. People living with HIV are at a much greater risk.

Fact 3
A total of 1.77 million people died from TB in 2007 (including 456 000 people with HIV), equal to about 4800 deaths a day. TB is a disease of poverty, affecting mostly young adults in their most productive years. The vast majority of TB deaths are in the developing world, with more than half occurring in Asia.

Fact 4
TB is a leading killer among people living with HIV, who have weakened immune systems.

Fact 5
There were 9.27 million new TB cases in 2007, of which 80% were in just 22 countries. Per capita, the global TB incidence rate is falling, but the rate of decline is very slow - less than 1%.

Fact 6
TB is a worldwide pandemic. Among the 15 countries with the highest estimated TB incidence rates, 13 are in Africa, while half of all new cases are in six Asian countries (Bangladesh, China, India, Indonesia, Pakistan and the Philippines).

Fact 7
Multidrug-resistant TB (MDR-TB) is a form of TB that does not respond to the standard treatments using first-line drugs. MDR-TB is present in virtually all countries surveyed by WHO and its partners.

Fact 8
There were an estimated 511 000 new MDR-TB cases in 2007 with three countries accounting for 56% of all cases globally: China, India and the Russian Federation. Extensively drug-resistant TB (XDR-TB) occurs when resistance to second-line drugs develops. It is extremely difficult to treat and cases have been confirmed in more than 50 countries.

Fact 9
WHO’s Stop TB Strategy aims to reach all patients and achieve the target under the Millennium Development Goals (MDG): to reduce by 2015 the prevalence of and deaths due to TB by 50% relative to 1990 and reverse the trend in incidence. The strategy emphasizes the need for proper health systems and the importance of effective primary health care to address the TB epidemic.

Fact 10
The Global Plan to Stop TB 2006-2015, launched January 2006, aims to achieve the MDG target with an investment of US$ 67 billion. This represents more than a three-fold increase in investment from 2005. The estimated funding gap is US$ 40 billion.

Declaration

Declaration of interests:
No conflicts of interest were delacred.

Application date: October 8, 2010
Last updated: September 14, 2011